Epstein Memorial Lecture

Dr Edward Epstein

The Epstein Lecture is dedicated to the late Dr Edward Epstein, who was the South African pioneer in the development of pseudophakic correction in cataract surgery in the fifties. He was a founding member and honorary member of the SASCRS.

This lecture is given at a Congress of the SASCRS by an ophthalmologist who has distinguished himself by outstanding international and local contributions for the advancement of cataract or refractive surgery.

The purpose of this Award is to recognize an Ophthalmologist’s consistent participation as an Ophthalmologist, in charitable activities, indigent care, community service and other humanitarian activities.

The qualifying criteria:

  • The nominee must have demonstrated a pattern of humanitarian service in Africa over a period of several years. Qualifying service might include, but not limited to, care for the indigent, service in inner city or rural African locations with disadvantaged persons, care for underprivileged individuals of specific racial or ethnic background and care in settings of high risk to the Ophthalmologist.
  • Service must have been above and beyond the usual service commitment required of an Ophthalmologist.
  • The service should have entailed personal sacrifice on the part of the Ophthalmologist.
  • Only one such Award may be given to an individual during his or her lifetime.

Epstein Lecturers

1999 Roberto Zaldivar, MD
2001 Emanuel S Rosen, MD
2003 Michael Knorz, MD
2005 Spencer Thornton, MD
2009 Dr Hubrecht Brody
2013 Dr Frik Potgieter
2015 Prof Andries A Stulting
2017 Prof Robert C Stegmann

Prof Robert C Stegmann

Prof. Stegmann started work on sodium hyaluronate (Healon) in 1977 and 1978 with Prof. David Miller of Harvard Medical School U.S.A. This was completed in South Africa in October 1978.

This resulted in the most significant advance in ophthalmic surgery facilitating the development of visual rehabilitation by a quantum leap.

Use of Healon in Ophthalmology extended to: -
- surgical treatment of congenital abnormalities of the anterior segment
- corneal grafts
- glaucoma surgery
- repair of trauma

To date more than 200 million people worldwide have benefited from this original research work carried out in Harvard Medical School (Boston) and Medunsa.

Refinement of surgical techniques as a result of the use of sodium hyaluronate, have led to Department of Ophthalmology in Medunsa being recognized as a world leader in ophthalmic surgery. This is best illustrated by achievement of highest success rate and lowest complication rate in the world today.

To back these facts, the following international recognition has been accorded:

  1. Temaign-deHoneur
    Canadian Ophthalmological Society, Toronto, June 1985

  2. Order of the Southern Cross (Silver)
    Cape Town, February 1987

  3. APPI Crystal Award
    Japan, January 1990

  4. Innovator’s Award
    American Society of Cataract and Refractive Surgery, Boston, March 1991

  5. American Academy of Ophthalmology Honour Award, October 1992

  6. Binkhorst Medal, European Society of Cataract and Refractive Surgery, October 1996

  7. Von Graefe Medal (Germany) 2001

  8. All Africa Innovators award received, Nov 2006 in Egypt.

  9. Sir Harold Ridley Medal, June 2007

  10. Funkhauser Medal Swiss Ophthalmological Society, 2008

  11. Canadian Ophthalmological Society Letson Lecture, September 2011

  12. Obstbaum Medal Lecture American Society of Cataract and Refractive
    Surgery April 2012.

This achievements have led to a number of children who were previously considered inoperable, to a situation where they could go to tertiary education as a result of Prof. Stegmann’s surgical intervention.

This has also led to most satisfying glaucoma surgery ever developed with most fascinating results.

Prof. Stegmann has developed many surgical instruments with international companies which have included special microscissors, microdiamond scalpels and most accurate surgical trephine yet designed.

Prof. Stegmann’s developed photographic techniques that are now recognized as the highest standard in the world today and have been used for teaching all over the world.

Over the years Prof. Stegmann’s stature has brought a significant amount of money to the Department of Ophthalmology, Medunsa (± R5 million worth of donations from industry both national and international). This includes ± R2 million in grants from First National Bank in recognition of the important medical research developed at Medunsa.

Overseas companies donated more than R3 m in instruments and devices for the benefit of the community served by Medunsa and Ga-Rankuwa Hospital. This was in recognition of the advances in surgical techniques for the treatment of cataracts, glaucoma, trauma and congenital diseases.

Prof. Stegmann has given 30 years of unbroken service to Medunsa without even taking sabbatical leave.

Close collaboration and ongoing research has been established internationally between Medunsa and following universities / institutions:

  • Harvard Medical School
  • MIT (Massachusetts Institute of Technology)
  • Uppsala (Sweden)
  • University of Antwerp (Belgium)
  • Gothenburg (Sweden)
  • Medical University of South Carolina (USA)
  • University of Cairo (Egypt)

In recognition of these achievements, patients from all over the world have received treatment and surgery at Medunsa / Ga-Rankuwa Hospital complex.
I.e. Sweden, Greece, USA, Switzerland, Italy, Malawi, Mauritius, Swaziland, Botswana, Lesotho, Angola, Zambia, Congo, Ethiopia, Ghana.

This has sparked tremendous interest and has led to doctors from all over the world visiting the department to be familiarized with surgical techniques.
I.e. Sweden, Norway, Germany, Italy, Greece, Spain, England, Japan, USA, Australia, Belgium, France, Switzerland, Uganda.

The ophthalmologists who graduated from Medunsa continue to serve the country and other parts of the world with distinction.